Cargando…

Atractylenolide-I covalently binds to CYP11B2, selectively inhibits aldosterone synthesis, and improves hyperaldosteronism

Hyperaldosteronism is a common disease that is closely related to endocrine hypertension and other cardiovascular diseases. Cytochrome P450 11B2 (CYP11B2), an important enzyme in aldosterone (ALD) synthesis, is a promising target for the treatment of hyperaldosteronism. However, selective inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenjuan, Li, Zhenqiang, Chu, Simeng, Ma, Xiaoyao, Wang, Xiaoying, Jiang, Min, Bai, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799885/ https://www.ncbi.nlm.nih.gov/pubmed/35127376 http://dx.doi.org/10.1016/j.apsb.2021.09.013

Ejemplares similares

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism
por: Okazaki‐Hada, Mikiko, et al.
Publicado: (2020)

Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism
por: Hussain, S, et al.
Publicado: (2015)

Aldosterone/Direct Renin Concentration Ratio Versus Aldosterone/Plasma Renin Activity for Diagnosis of Primary Hyperaldosteronism: Case Presentation
por: Shanik, Michael Howard, et al.
Publicado: (2021)

UPLC-MS/MS of Atractylenolide I, Atractylenolide II, Atractylenolide III, and Atractyloside A in Rat Plasma after Oral Administration of Raw and Wheat Bran-Processed Atractylodis Rhizoma
por: Xu, Shizhao, et al.
Publicado: (2018)

Atractylenolide I inhibits antibiotic-induced dysbiosis of the intestinal microbiome
por: Liu, Penglin, et al.
Publicado: (2021)

Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1
por: Takeda, Yoshimichi, et al.
Publicado: (2023)

Spatially restricted substrate-binding site of cortisol-synthesizing CYP11B1 limits multiple hydroxylations and hinders aldosterone synthesis
por: Mukai, Kuniaki, et al.
Publicado: (2021)

Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation
por: Schewe, Julia, et al.
Publicado: (2019)

Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study
por: Takizawa, Nae, et al.
Publicado: (2021)

Cinnamaldehyde Enhances Antimelanoma Activity through Covalently Binding ENO1 and Exhibits a Promoting Effect with Dacarbazine
por: Zhang, Weiyi, et al.
Publicado: (2020)

THU591 HyperAldosteronism In Pregnancy Predicted Impacts (H.A.P.P.I.): A Retrospective Cohort Study
por: Oprea, Diana, et al.
Publicado: (2023)

Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2016)

The Role of the CYP11B2 Promoter Polymorphism in the Diagnosis of Primary Aldosteronism
por: Żukowski, Łukasz, et al.
Publicado: (2020)

Neuroblastoma accompanied by hyperaldosteronism
por: Gulleroglu, Kaan, et al.
Publicado: (2014)

High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells
por: Shimada, Hiroki, et al.
Publicado: (2017)

Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells
por: Long, Fangyi, et al.
Publicado: (2017)

Correction to: Anti-tumor effects of Atractylenolide I on bladder cancer cells
por: Yu, Rui, et al.
Publicado: (2018)

Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson’s Disease
por: More, Sandeep, et al.
Publicado: (2017)

Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
por: Chan, Ka Woon Karen, et al.
Publicado: (2020)

Development of [(18)F]AldoView as the First Highly Selective Aldosterone Synthase PET Tracer for Imaging of Primary Hyperaldosteronism
por: Sander, Kerstin, et al.
Publicado: (2021)

Author Correction: Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation
por: Schewe, Julia, et al.
Publicado: (2022)

Genetic Analyses of the Chimeric CYP11B1/CYP11B2 Gene in a Korean Family with Glucocorticoid-Remediable Aldosteronism
por: Lee, Ihn Suk, et al.
Publicado: (2010)

Exploration of KCNJ5 Somatic Mutation and CYP11B1/CYP11B2 Staining in Multiple Nodules in Primary Aldosteronism
por: Xie, Jing, et al.
Publicado: (2022)

Renin angiotensin aldosterone system altered in resistant hypertension in Sub-Saharan African diabetes patients without evidence of primary hyperaldosteronism
por: Edinga-Melenge, Bertille Elodie, et al.
Publicado: (2017)

A Randomized Pilot Study of Atractylenolide I on Gastric Cancer Cachexia Patients
por: Liu, Yi, et al.
Publicado: (2008)

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry
por: Stenman, Adam, et al.
Publicado: (2019)

Immunohistochemical Analysis of CYP11B2, CYP11B1 and β-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism
por: Sun, Luyan, et al.
Publicado: (2021)

LBODP025 A Novel Drug Discovery For Primary Aldosteronism Targeting Aldosterone Synthase (cyp11b2) And Kcnj5 Mutant
por: Otsubo, Yuri, et al.
Publicado: (2022)

ODP144 Cushing Syndrome and Primary Hyperaldosteronism due to Synchronic Bilateral Adrenal Adenomas with Exclusive Production of Cortisol on the Right and Aldosterone on the Left
por: Rolim, Marina Rocha, et al.
Publicado: (2022)

P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells
por: Han, Yue, et al.
Publicado: (2022)

Effects of ACTH, dexamethasone, and adrenalectomy on 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system
por: Ye, Ping, et al.
Publicado: (2008)

SUN-711 Association of Single Nucleotide Polymorphisms of CYP11B2, CYP11B1 and CYP17A1 with Primary Aldosteronism in a Multi-Ethnic Malaysian Cohort
por: Azam, Afifah, et al.
Publicado: (2020)

Changes in the Perceived Epidemiology of Primary Hyperaldosteronism
por: Fagugli, Riccardo Maria, et al.
Publicado: (2011)

Primary hyperaldosteronism: challenges in subtype classification
por: Layden, Brian T, et al.
Publicado: (2012)

An Association of Chronic Hyperaldosteronism with Medullary Nephrocalcinosis
por: Mittal, Kartik, et al.
Publicado: (2015)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Multiple corticosteroid abnormalities in cats with hyperaldosteronism
por: Langlois, Daniel K., et al.
Publicado: (2021)

FRI416 Primary Hyperaldosteronism in Pregnancy
por: Seav, Susan M, et al.
Publicado: (2023)

GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
por: Wu, Yu-Ching, et al.
Publicado: (2022)

SAT-196 The Use of (11)C-metomidate PET-CT to Detect Unilateral Primary Hyperaldosteronism
por: Harjanto, Sumitro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lo15mcm0up6b2h646t8s8m4r4t